Using Monoclonal Antibody Treatments for COVID-19 Positive Patients

As variants circulate, cases of COVID-19 are on the rise again. The current variants have not only been shown to be more contagious, they have also proven to break through vaccinations.

To prevent hospitalizations and deaths, monoclonal antibodies have recently been approved by the FDA under Emergency Use Authorization for those who develop or are exposed to COVID-19, have mild or moderate symptoms and are at high risk of developing severe illness.

Join expert Steven Atkinson, PA-C, MS, for this FREE Live Webinar as he examines early results of this treatment and its level of effectiveness.

You must reserve your seat to join this live webinar, so Register Now!

Using Monoclonal Antibody Treatments for COVID-19 Positive Patients

October 14th 12:00PM - 1:00PM CST

Yours FREE — sign up today!

REGISTER FOR FREE

Can’t attend the live webinar? No worries. Reserve your seat and we’ll make sure you get unlimited access to the recording.

Objectives:

Determine what monoclonal antibodies are and the purpose they serve for patients with COVID-19.
Distinguish between eligible and ineligible patient types for monoclonal antibodies.
Inspect early treatment results to determine the level of effectiveness.

Outline:

Monoclonal Antibodies – Overview and Purpose
Research and Treatment Results
FDA Authorization and Patient Eligibility
What’s Next

Meet your Speaker:

Steven Atkinson, PA-C, MS, is a Board-Certified Physician Assistant specializing in Geriatric Internal Medicine. He practices medicine in the greater Minneapolis area and is involved in pharmacological and pain management challenges daily. In addition to his private practice, he has been on the faculty at the University of Utah since 1994 and has been involved in medicine for over 30 years. Steven is the co-founder of Twin Cities Physicians, which serves older adults in nearly all levels of their care. He has presented nationally on a variety of topics that draw from his specialty expertise. Steven is the author of Geriatric Pharmacology: The Principles of Practice & Clinical Recommendations, Second Edition and sits on several boards whose purpose is to elevate the level of care in medicine for the patients they serve. Steven has been described as a "dynamic" educator and one of the most engaging presenters around.

Click here for information about Steven Atkinson

Using Monoclonal Antibody Treatments for COVID-19 Positive Patients

October 14th 12:00PM - 1:00PM CST
Yours FREE — sign up today!

REGISTER FOR FREE

Can’t attend the live webinar? No worries. Reserve your seat and we’ll make sure you get unlimited access to the recording.

Back to Top